Here is my .02, this is a safety study only. Right now the drug has not been tested for safety to use together. Yes they are both approved but we don't know if the combo can cause problems. So once the safety study is complete they will be able to change the label and state that it has been tested in combination with Phen. I am not sure they are going to be very public about the weight loss results, we are getting those from the weight loss clinics. We may get the weight loss differences with the three different dosing levels.
I was hoping for S. Korea news from the Study, it was completed a while ago.
They lost patent protection on major drug and the generics are cutting in fats. That is the reason to lock in new novel drugs so they can continue to grow, I.e. Buying world wide rights to Belviq and 4 other up and coming drugs.
You need to view the entire picture good and bad. Other countries are having the same issues the FDA had with the final study data and if they don't agree with the non clinical study or it's results we end up with an application that can't be approved. Remember ARNA did not even address the rat tumor issues in the first submission, they felt it was a non issue and they were grossly wrong and cost shareholders millions of dollars and potentially billions with that bad call. Craig Audit still had a job after that train wreck.
Company has lots of potential and the pipeline looks amazing, but Wall Street is betting that management is not good enough to pull it off in its current form.
Why do you need to lie like that? Are you really that desperate? Jake stated on the call he has no long term sell plan in place after the last sale.
We are nervous about q over q of 40+%? I don't think so. Nervous about 600 reps now on the street following 3 months of DTC? I don't think so. 330,000 scripts in first 12 months? Nope
Only ones bombarding the board are the shorts and the baskets who need longs to sell so they can cove.
The drug is already approved and was scripted 330,000 times in the first year of being on the market. We know from real world users that not only does it curb food cravings but alcohol and smoking cravings. Nothing hyped about it, just facts. You are the one spinning facts. I know many smokers that won't quit because they gain weight when they try. It is a universal complaint, and it is only prudent to run a study to determine if it is statistically superior to what is on the market.
Only been on the market for 13 months. It is not well known that it works and many doctors will not script a new drug until it has been on the market for a year or ore. When the drug launched I saw a news interview and 11 out of 12 doctors stated they were not going to script a new weight loss drug. They wanted to see real world results.
Did you expect anything different? Everyone talks their book. They will spin,lie and ignore the facts. Longs are not expecting us to run to 20 buck but we do expect the stock to hold its value while we release nothing but good news. New drug in a monster market, with many harmful failures, and we still are doing well.
Yup, if the results are really good, many des will script it. Problem is they won't get insurance coverage until it is approved as a smoking drug.
50 dollars is nothing when you consider what a meal plan or fake weight loss supplements cost. When it becomes known that the drug works to everyday people they will spend the money. Eisai said many were starting but waiting to continue until coverage..